Cargando…
Proton pump inhibitors alter the composition of the gut microbiota
OBJECTIVE: Proton pump inhibitors (PPIs) are drugs used to suppress gastric acid production and treat GI disorders such as peptic ulcers and gastro-oesophageal reflux. They have been considered low risk, have been widely adopted, and are often over-prescribed. Recent studies have identified an incre...
Autores principales: | Jackson, Matthew A, Goodrich, Julia K, Maxan, Maria-Emanuela, Freedberg, Daniel E, Abrams, Julian A, Poole, Angela C, Sutter, Jessica L, Welter, Daphne, Ley, Ruth E, Bell, Jordana T, Spector, Tim D, Steves, Claire J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853574/ https://www.ncbi.nlm.nih.gov/pubmed/26719299 http://dx.doi.org/10.1136/gutjnl-2015-310861 |
Ejemplares similares
-
Proton pump inhibitors affect the gut microbiome
por: Imhann, Floris, et al.
Publicado: (2016) -
Who uses probiotics and why? A survey study conducted among general gastroenterology patients
por: Lynch, Elissa, et al.
Publicado: (2021) -
Gestational diabetes is driven by microbiota-induced inflammation months before diagnosis
por: Pinto, Yishay, et al.
Publicado: (2023) -
Postinfective bowel dysfunction following Campylobacter enteritis is characterised by reduced microbiota diversity and impaired microbiota recovery
por: Jalanka, Jonna, et al.
Publicado: (2023) -
The oral microbiota in colorectal cancer is distinctive and predictive
por: Flemer, Burkhardt, et al.
Publicado: (2018)